KMI
26.18
+0.46%↑
SLB
36.04
-0.74%↓
VLO
169.49
-0.38%↓
BKR
48.41
-0.35%↓
EQT
53.71
+2.3%↑
KMI
26.18
+0.46%↑
SLB
36.04
-0.74%↓
VLO
169.49
-0.38%↓
BKR
48.41
-0.35%↓
EQT
53.71
+2.3%↑
KMI
26.18
+0.46%↑
SLB
36.04
-0.74%↓
VLO
169.49
-0.38%↓
BKR
48.41
-0.35%↓
EQT
53.71
+2.3%↑
KMI
26.18
+0.46%↑
SLB
36.04
-0.74%↓
VLO
169.49
-0.38%↓
BKR
48.41
-0.35%↓
EQT
53.71
+2.3%↑
KMI
26.18
+0.46%↑
SLB
36.04
-0.74%↓
VLO
169.49
-0.38%↓
BKR
48.41
-0.35%↓
EQT
53.71
+2.3%↑
24h
Praegune
Min
1.71
Max
1.72
Sissetulek | -10M -21M |
|---|---|
Müük | -12M 10M |
Kasumimarginaal | -200.824 |
Töötajad | 101 |
EBITDA | -9.8M -19M |
Soovitused | Tugev "osta" hinnang |
|---|---|
12 kuu keskmine prognoos | +41.28% upside |
Järgmine tulemuste avaldamine | 4. nov 2025 |
|---|
Turukapital | 156M 605M |
|---|---|
Eelmine avamishind | 0.53 |
Eelmine sulgemishind | 1.71 |
Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.
31. okt 2025, 17:40 UTC
Orange to Buy Lorca's 50% Stake in MasOrange for $4.9 Billion
DJ
Loe
1. nov 2025, 12:56 UTC
Berkshire's Quarterly Earnings Rise After Insurance Results Improve -- WSJ
DJ
Loe
1. nov 2025, 12:56 UTC
Berkshire Operating Profits Rose 33% in Third Quarter. There Were No Stock Buybacks. -- Barrons.com
DJ
Loe
1. nov 2025, 12:20 UTC
Berkshire Operating Profits Rose 33% in Third Quarter. There Were No Stock Buybacks. -- Barrons.com
DJ
Loe
1. nov 2025, 12:19 UTC
Berkshire Operating Profits Rose 33% in Third Quarter. There Were No Stock Buybacks. -- Barrons.com
DJ
Loe
1. nov 2025, 08:20 UTC
Financial Services Roundup: Market Talk
DJ
Loe
1. nov 2025, 08:20 UTC
Basic Materials Roundup: Market Talk
DJ
Loe
1. nov 2025, 00:10 UTC
Trouble on The Strip -- Barrons.com
DJ
Loe
31. okt 2025, 23:09 UTC
Review & Preview: October Surprise -- Barrons.com
DJ
Loe
31. okt 2025, 22:44 UTC
Pfizer Sues Seeking to Block Novo Nordisk's Effort to Undo Weight-Loss Drug Deal -- WSJ
DJ
Loe
31. okt 2025, 21:25 UTC
Pfizer Says Novo Nordisk's Metsera Bid Won't Pass Antitrust Laws -- Market Talk
DJ
Loe
31. okt 2025, 21:20 UTC
Pfizer Sues Seeking to Block Novo Nordisk's Effort to Undo Weight-Loss Drug Deal -- Update
DJ
Loe
31. okt 2025, 21:12 UTC
Pfizer Sues Metsera, Novo Nordisk, Claiming Novo Nordisk Takeover Offer Isn't Superior -- WSJ
DJ
Loe
31. okt 2025, 21:12 UTC
Pfizer Sues Seeking to Block Novo Nordisk's Effort to Undo Weight-Loss Drug Deal -- WSJ
DJ
Loe
31. okt 2025, 21:12 UTC
Pfizer Seeks Order Blocking Metsera From Terminating Its Merger Deal With Pfizer -- WSJ
DJ
Loe
31. okt 2025, 20:51 UTC
Another Rare-Earth Stock Jumps on Government Deal -- Barrons.com
DJ
Loe
31. okt 2025, 20:50 UTC
Financial Services Roundup: Market Talk
DJ
Loe
31. okt 2025, 20:50 UTC
Basic Materials Roundup: Market Talk
DJ
Loe
31. okt 2025, 20:50 UTC
Auto & Transport Roundup: Market Talk
DJ
Loe
31. okt 2025, 20:46 UTC
Pfizer: Files Lawsuit Against Metsera and Its Directors and Novo Nordisk for Breach of Merger Agreement
DJ
Loe
31. okt 2025, 20:22 UTC
Amazon Stock Hits New Record. What Was So Good in Its Earnings Report. -- Barrons.com
DJ
Loe
31. okt 2025, 20:02 UTC
Meta Faces a Sudden Reckoning. How Big Tech Earnings Are Reshaping the AI Race. -- Barrons.com
DJ
Loe
31. okt 2025, 19:55 UTC
Crude Futures Fall for Third Straight Month -- Market Talk
DJ
Loe
31. okt 2025, 19:54 UTC
Pfizer: FTC Granted Early Termination of Waiting Period >PFE
DJ
Loe
31. okt 2025, 19:54 UTC
Pfizer: Receives Early Clearance From FTC for Metsera Acquisition
DJ
Loe
31. okt 2025, 19:26 UTC
U.S. Natural Gas Rises on Winter Outlook, Strong LNG -- Market Talk
DJ
Loe
31. okt 2025, 18:30 UTC
These Stocks Are Moving the Most Today: Amazon, Nvidia, Apple, Netflix, Exxon, DexCom, Coinbase, Reddit, Newell Brands, and More -- Barrons.com
DJ
Loe
31. okt 2025, 18:23 UTC
Gold Edges Lower for the Day, Closes October Positive -- Market Talk
DJ
Loe
31. okt 2025, 18:09 UTC
Bank of America Has a Game Plan to Catch Up to Its Peers. It's Time to Buy the Stock. -- Barrons.com
DJ
Loe
31. okt 2025, 18:08 UTC
Bank of America Has a Game Plan to Catch Up to Its Peers. It's Time to Buy the Stock. -- Barrons.com
DJ
Loe
Hinnamuutus
By TipRanks
12 kuu keskmine prognoos
Keskmine 2.43 USD 41.28%
Kõrge 3 USD
Madal 1.8 USD
Põhineb 5 Wall Streeti analüütiku instrumendi Ur-Energy Inc 12 kuu hinnasihil - viimase 3 kuu andmed.
By TipRanks
Tugev "osta" hinnang
5 ratings
5
Osta
0
Hoia
0
Müü
Põhineb 5 analüütiku instrumendi Ur-Energy Inc aktsia reitingul - viimase 3 kuu andmed.
Müügi- ja halduskulud
Tegevuskulud
Maksueelne kasum
Müük
Müügikulu
Brutokasum müügist
Intressikulud võla pealt
EBITDA
Ärikasum
$